Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.31 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20122206 | 0.83 | ATM (0.43) | KMT2AALDH1A1ATMHPGDTSHR | |
| SCHEMBL28399016 | 0.75 | KMT2A (0.36) | KMT2A | |
| SCHEMBL11746058 | 0.72 | — | — | |
| SCHEMBL1259220 | 0.70 | — | — | |
| SCHEMBL8355774 | 0.68 | KMT2A (0.37) | KMT2A | |
| SCHEMBL10954117 | 0.67 | KMT2A (0.62) | KMT2AALDH1A1ATMTSHR | |
| SCHEMBL4178226 | 0.64 | ALDH1A2 (0.43) | KMT2AALDH1A2ALDH1A1ALDH2ALDH1A3 | |
| SCHEMBL22545925 | 0.61 | HTT (0.58) | ALDH1A1HPGDTSHR | |
| SCHEMBL27433004 | 0.60 | ALDH1A1 (0.43) | KMT2AALDH1A2ALDH1A1ALDH2ALDH1A3 | |
| SCHEMBL29102358 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240217917-A1 | PHOTOLYTICALLY DEGRADABLE COMPOUNDS AND METHODS | THE UNIVERSITY OF STAVANGER (NO) | 2024-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240217917-A1 | PHOTOLYTICALLY DEGRADABLE COMPOUNDS AND METHODS | DDT, DDC, CTRC | KMT2A 2563/4885ALDH1A2 618/4885ALDH1A1 1873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.